US Patent Issued to MEDYTOX on Sept. 23 for "Extracellular vesicles derived from recombinant microorganism including polynucleotide encoding target protein and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,836, issued on Sept. 23, was assigned to MEDYTOX INC. (Cheongju-si, South Korea).

"Extracellular vesicles derived from recombinant microorganism including polynucleotide encoding target protein and use thereof" was invented by Ji Ae Yun (Suwon-si, South Korea), Hyun Uk Jeong (Suwon-si, South Korea), Jin Ho Choo (Bucheon-si, South Korea), Soo Min Song (Yongin-si, South Korea), Ji Yoon Song (Seongnam-si, South Korea), Yong In Kim (Seongnam-si, South Korea) and Seung Kee Cho (Suwon-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are extracellular vesicles (EVs) derived from a recombinant microorganism including one or more poly...